Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

GERN Geron Corp

3,45

-0,12 (-3,36%)

07 Jan 2025 - Fermé

Retardé de 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Geron (NASDAQ:GERN)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Geron

Geron (NASDAQ:GERN)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Geron

Actualités Geron Corp

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 2 Janvier 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jeudi 19 Décembre 2024 ( il y a 3 semaines) • Business Wire

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS
Vendredi 13 Décembre 2024 ( il y a 4 semaines) • Business Wire

Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis
Mardi 10 Décembre 2024 ( il y a 4 semaines) • Business Wire

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Mercredi 27 Novembre 2024 ( il y a 1 mois) • Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jeudi 21 Novembre 2024 ( il y a 2 mois) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
Lundi 11 Novembre 2024 ( il y a 2 mois) • Business Wire

Geron to Participate in the Stifel 2024 Healthcare Conference
Lundi 11 Novembre 2024 ( il y a 2 mois) • Business Wire

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
Jeudi 7 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Business Wire

Plus d'articles sur Geron Corp

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales